The impact of pricing strategy on the costs of oral anti‐cancer drugs

BACKGROUND: The soaring costs of anti‐cancer drugs pose a threat to the sustainability of cancer care. The pricing strategy chosen by manufacturers can impact the costs of oral anti‐cancer drugs during dose modifications, but this issue remains under‐recognized in the literature. In general, with th...

Descripción completa

Detalles Bibliográficos
Autores principales: Truong, Judy, Chan, Kelvin K. W., Mai, Helen, Chambers, Alexandra, Sabharwal, Mona, Trudeau, Maureen E., Cheung, Matthew C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Clinical Cancer Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6639183/
https://www.ncbi.nlm.nih.gov/pubmed/31132223
http://dx.doi.org/10.1002/cam4.2269

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6639183/
https://www.ncbi.nlm.nih.gov/pubmed/31132223
http://dx.doi.org/10.1002/cam4.2269

Ejemplares similares